GSK's COPD drug Nucala approved for market launch by the European Union
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, February 6th｜GlaxoSmithKline announced today that the European Commission has approved its monoclonal antibody maintenance therapy drug Nucala for uncontrolled chronic obstructive pulmonary disease (COPD). GlaxoSmithKline stated that this approval is based on positive data from the MATINEE Phase III clinical trial. There are over 390 millions COPD patients worldwide, with approximately 40 millions in Europe.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
At 21:30 today, the US October PPI annual rate and other data will be released.
Chaincatcher•2026/11/13 02:03
After Nvidia (NVDA.US) plunged 32%, Goldman Sachs cited the Apple precedent, while Fundstrat even called for “buying the dip.”
After Nvidia plunged by 32%, Goldman Sachs suggested, drawing parallels with Apple, that its valuation might face pressure before recovering. Tom Lee advocated for "buying the dip," with all differing opinions pointing to declines as investment opportunities.
智通财经•2026/11/13 01:48
BTC surpasses $71,000
金色财经•2026/11/13 01:25
Crypto prices
More
Bitcoin
BTC
$70,727.95
-4.03%
Ethereum
ETH
$2,006.06
-2.28%
Tether USDt
USDT
$0.9988
+0.01%
BNB
BNB
$653.2
-3.58%
USDC
USDC
$0.9998
+0.00%
XRP
XRP
$1.03
-1.94%
Solana
SOL
$80.99
-2.61%
TRON
TRX
$0.3151
-0.51%
Hyperliquid
HYPE
$72.71
+1.32%
Zcash
ZEC
$952.69
-4.42%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now